Actively Recruiting
Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer
Led by Gustave Roussy, Cancer Campus, Grand Paris · Updated on 2026-05-08
170
Participants Needed
3
Research Sites
95 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The U-TRANS study was initiated by Gustave Roussy, which is its sponsor\*. It is part of the Interception Program and aims to reduce the consumption of ultra-processed foods in order to improve the overall quality of the diet among people at high risk of cancer (WCRF score ≤ 5, corresponding to low adherence to nutritional cancer prevention recommendations: eating a diet rich in whole grains, vegetables, fruit and fibre, and limiting ultra-processed foods, red meat, processed meats, sugary drinks and alcohol). It assesses the impact of a digital intervention (based on the use of the Open Food Facts app) as a complement to the nutritional education provided by the Interception program.
CONDITIONS
Official Title
Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18 years
- Individuals at increased risk of different cancers as defined within the Interception program
- Baseline WCRF score ≤ 5 at entry in the Interception program
- Agree to participate and provide written consent
- Agree to complete questionnaires on the study platform during the study
- Have and accept to use a smartphone
- Understand spoken and written French language
You will not qualify if you...
- Psychiatric disorders or cognitive impairments preventing participation
- Under guardianship, deprived of liberty by judicial or administrative decision, or unable to give consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Institut Sainte Catherine
Avignon, France, 84918
Not Yet Recruiting
2
Eugène Marquis
Rennes, France, 25042
Actively Recruiting
3
Gustave Roussy
Villejuif, France, 94800
Actively Recruiting
Research Team
B
Bruno Raynard, MD
CONTACT
A
Adeline Salasc, Pharm D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here